This Article Full Text Full Text (PDF) All Versions of this Article: 51/3/597    most recent HYPERTENSIONAHA.107.097154v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stec, D. E. Articles by Vera, T. Search for Related Content PubMed PubMed Citation Articles by Stec, D. E. Articles by Vera, T. Related Collections Animal models of human disease Other hypertension Endothelium/vascular type/nitric oxide

(Hypertension. 2008;51:597.)
© 2008 American Heart Association, Inc.

Brief Reviews

Role of Carbon Monoxide in Blood Pressure Regulation

From the Department of Physiology and Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson.

Correspondence to David E. Stec, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216-4505. E-mail dstec@physiology.umsmed.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Carbon monoxide (CO) is an odorless, colorless, tasteless gas that is generated in the environment as the result of combustion from stoves and engines among other sources. Approximately 500 people per year in the United States are victims of nonfire-associated CO poisoning according to the Centers for Disease Control and Prevention. CO poisoning is often fatal because of its interaction with hemoglobin, which renders it incapable of carrying oxygen-causing organs to become severely hypoxic. CO inhalation is believed to be fatally toxic at concentrations as little as 800 parts per million (ppm) or 0.08% in the air. Despite the lethal nature of this gas, several recent studies suggest that CO inhalation at low doses (250 ppm), as well as increases in CO levels using CO releasing molecules (CORMs), offers protection against ischemic injury in the heart, liver, and kidney.^1–4

CO is endogenously produced in the body as a result of the metabolism of heme by heme oxygenase (HO), as well as from lipid peroxidation.^5,6 The catabolism of heme by HO also produces an equimolar amount of biliverdin, which is rapidly converted in the cell to bilirubin by the enzyme biliverdin reductase.⁷ There are 2 major isoforms of HO responsible for CO production. HO-1 is expressed at very low levels under normal conditions but is highly induced by several stimuli, including heavy metals, ultraviolet light, endotoxin, shear stress, hypoxia, and oxidants.⁸ HO-2 is the constitutively expressed form of the enzyme with the highest levels observed in the brain and testes.⁹ . . . [Full Text of this Article]

This article has been cited by other articles:

				N. G. Abraham, J. Cao, D. Sacerdoti, X. Li, and G. Drummond Heme oxygenase: the key to renal function regulation Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1137 - F1152. [Abstract] [Full Text] [PDF]

				A. C. da Costa-Goncalves, J. Tank, R. Plehm, A. Diedrich, M. Todiras, M. Gollasch, A. Heuser, M. Wellner, M. Bader, J. Jordan, et al. Role of the Multidomain Protein Spinophilin in Blood Pressure and Cardiac Function Regulation Hypertension, October 1, 2008; 52(4): 702 - 707. [Abstract] [Full Text] [PDF]